29/01/2010
Within the framework of the European Regions of Knowledge Work Programme (FP7), Biopol has submitted a proposal to the Eurobiomarkers project. This initiative aims to support and encourage the cooperation of the following four ‘research-driven clusters’ across Europe: Alsace (France), Negev (Israel), Piedmont (Italy) and Biopol'H (Catalonia). The objective of this project is to improve the competitiveness of health-related industries and enterprises in each region. Special attention is paid to biomarkers focusing on personalized therapies for central nervous system diseases and cancer.
In order to join one of the European Regions of Knowledge and to participate in this call, the Biopol'H Consortium, Ferrer International Laboratories and the Bellvitge Institute for Biomedical Research (IDIBELL) have signed a collaboration agreement that aims to turn the Biopol area, where these entities are located, into an international reference in the science and technology field. These three entities will promote collaboration and cooperation in research, development and innovation between public and private sectors in strategically important areas in the field of health.
22/06/2010
KIMbcn and Biopol'H organized last thursday June 17th the first breakfast of Henry Chesbrough with managers of pharmaceutical companies. During the 
[+ photos]
17/05/2010
Manel Esteller, director of the program of Epigenetics and Cancer Biology of IDIBELL, has been awarded for a work that discovered a connection between
07/05/2010
Santiago Nofuentes, chief operating officer of Consorci Sanitari Integral - the Holistic Health Consortium – has presented the results of the
06/05/2010
A scientific study led by Genevieve Buckland and Carlos Alberto Gonzalez Svatetz from the Nutrition, Environment and Cancer Unit at ICO-IDIBELL has
03/05/2010
Ramon López - director of Consortium Biopol’H - and Santiago Nofuentes - chief executive officer of Consorci Sanitari Integral (Holistic
